Research from Rice University suggests the social reality of using GLP-1s may be more complicated. In some cases, using these medications may come with more judgment than not losing weight at all.
That’s the surprising finding behind a new study from Erin Standen, assistant professor of psychological sciences at Rice, published in the International Journal of Obesity with co-authors Sean Phelan, professor of health services research at the Mayo Clinic, and Janet Tomiyama, professor of psychology at the University of California, Los Angeles.
“We expected there might be some stigma around using a GLP-1,” Standen said. “But what surprised us was the extent of it.”
Visit: https://news.rice.edu/news/2026/glp-1-paradox-rice-study-finds-weight-loss-drugs-may-carry-unexpected-stigma
